Cargando…

An optimized small animal tumour model for experimentation with low energy protons

BACKGROUND: The long-term aim of developing laser based particle acceleration towards clinical application requires not only substantial technological progress, but also the radiobiological characterization of the resulting ultra-short and ultra-intensive particle beam pulses. After comprehensive ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Beyreuther, Elke, Brüchner, Kerstin, Krause, Mechthild, Schmidt, Margret, Szabo, Rita, Pawelke, Jörg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436688/
https://www.ncbi.nlm.nih.gov/pubmed/28545054
http://dx.doi.org/10.1371/journal.pone.0177428
_version_ 1783237449558786048
author Beyreuther, Elke
Brüchner, Kerstin
Krause, Mechthild
Schmidt, Margret
Szabo, Rita
Pawelke, Jörg
author_facet Beyreuther, Elke
Brüchner, Kerstin
Krause, Mechthild
Schmidt, Margret
Szabo, Rita
Pawelke, Jörg
author_sort Beyreuther, Elke
collection PubMed
description BACKGROUND: The long-term aim of developing laser based particle acceleration towards clinical application requires not only substantial technological progress, but also the radiobiological characterization of the resulting ultra-short and ultra-intensive particle beam pulses. After comprehensive cell studies a mouse ear tumour model was established allowing for the penetration of low energy protons (~20 MeV) currently available at laser driven accelerators. The model was successfully applied for a first tumour growth delay study with laser driven electrons, whereby the need of improvements crop out. METHODS: To optimise the mouse ear tumour model with respect to a stable, high take rate and a lower number of secondary tumours, Matrigel was introduced for tumour cell injection. Different concentrations of two human tumour cell lines (FaDu, LN229) and Matrigel were evaluated for stable tumour growth and fulfilling the allocation criteria for irradiation experiments. The originally applied cell injection with PBS was performed for comparison and to assess the long-term stability of the model. Finally, the optimum suspension of cells and Matrigel was applied to determine applicable dose ranges for tumour growth delay studies by 200 kV X-ray irradiation. RESULTS: Both human tumour models showed a high take rate and exponential tumour growth starting at a volume of ~10 mm(3). As disclosed by immunofluorescence analysis these small tumours already interact with the surrounding tissue and activate endothelial cells to form vessels. The formation of delimited, solid tumours at irradiation size was shown by standard H&E staining and a realistic dose range for inducing tumour growth delay without permanent tumour control was obtained for both tumour entities. CONCLUSION: The already established mouse ear tumour model was successfully upgraded now providing stable tumour growth with high take rate for two tumour entities (HNSCC, glioblastoma) that are of interest for future irradiation experiments at experimental accelerators.
format Online
Article
Text
id pubmed-5436688
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-54366882017-05-27 An optimized small animal tumour model for experimentation with low energy protons Beyreuther, Elke Brüchner, Kerstin Krause, Mechthild Schmidt, Margret Szabo, Rita Pawelke, Jörg PLoS One Research Article BACKGROUND: The long-term aim of developing laser based particle acceleration towards clinical application requires not only substantial technological progress, but also the radiobiological characterization of the resulting ultra-short and ultra-intensive particle beam pulses. After comprehensive cell studies a mouse ear tumour model was established allowing for the penetration of low energy protons (~20 MeV) currently available at laser driven accelerators. The model was successfully applied for a first tumour growth delay study with laser driven electrons, whereby the need of improvements crop out. METHODS: To optimise the mouse ear tumour model with respect to a stable, high take rate and a lower number of secondary tumours, Matrigel was introduced for tumour cell injection. Different concentrations of two human tumour cell lines (FaDu, LN229) and Matrigel were evaluated for stable tumour growth and fulfilling the allocation criteria for irradiation experiments. The originally applied cell injection with PBS was performed for comparison and to assess the long-term stability of the model. Finally, the optimum suspension of cells and Matrigel was applied to determine applicable dose ranges for tumour growth delay studies by 200 kV X-ray irradiation. RESULTS: Both human tumour models showed a high take rate and exponential tumour growth starting at a volume of ~10 mm(3). As disclosed by immunofluorescence analysis these small tumours already interact with the surrounding tissue and activate endothelial cells to form vessels. The formation of delimited, solid tumours at irradiation size was shown by standard H&E staining and a realistic dose range for inducing tumour growth delay without permanent tumour control was obtained for both tumour entities. CONCLUSION: The already established mouse ear tumour model was successfully upgraded now providing stable tumour growth with high take rate for two tumour entities (HNSCC, glioblastoma) that are of interest for future irradiation experiments at experimental accelerators. Public Library of Science 2017-05-18 /pmc/articles/PMC5436688/ /pubmed/28545054 http://dx.doi.org/10.1371/journal.pone.0177428 Text en © 2017 Beyreuther et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Beyreuther, Elke
Brüchner, Kerstin
Krause, Mechthild
Schmidt, Margret
Szabo, Rita
Pawelke, Jörg
An optimized small animal tumour model for experimentation with low energy protons
title An optimized small animal tumour model for experimentation with low energy protons
title_full An optimized small animal tumour model for experimentation with low energy protons
title_fullStr An optimized small animal tumour model for experimentation with low energy protons
title_full_unstemmed An optimized small animal tumour model for experimentation with low energy protons
title_short An optimized small animal tumour model for experimentation with low energy protons
title_sort optimized small animal tumour model for experimentation with low energy protons
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436688/
https://www.ncbi.nlm.nih.gov/pubmed/28545054
http://dx.doi.org/10.1371/journal.pone.0177428
work_keys_str_mv AT beyreutherelke anoptimizedsmallanimaltumourmodelforexperimentationwithlowenergyprotons
AT bruchnerkerstin anoptimizedsmallanimaltumourmodelforexperimentationwithlowenergyprotons
AT krausemechthild anoptimizedsmallanimaltumourmodelforexperimentationwithlowenergyprotons
AT schmidtmargret anoptimizedsmallanimaltumourmodelforexperimentationwithlowenergyprotons
AT szaborita anoptimizedsmallanimaltumourmodelforexperimentationwithlowenergyprotons
AT pawelkejorg anoptimizedsmallanimaltumourmodelforexperimentationwithlowenergyprotons
AT beyreutherelke optimizedsmallanimaltumourmodelforexperimentationwithlowenergyprotons
AT bruchnerkerstin optimizedsmallanimaltumourmodelforexperimentationwithlowenergyprotons
AT krausemechthild optimizedsmallanimaltumourmodelforexperimentationwithlowenergyprotons
AT schmidtmargret optimizedsmallanimaltumourmodelforexperimentationwithlowenergyprotons
AT szaborita optimizedsmallanimaltumourmodelforexperimentationwithlowenergyprotons
AT pawelkejorg optimizedsmallanimaltumourmodelforexperimentationwithlowenergyprotons